Insider Trading April 7, 2026

First Commonwealth Financial CFO Disposes of 2,072 Shares, Raising $37,006

James R. Reske's planned sales executed at incremental prices; executive still holds more than 83,000 shares and service-based RSUs

By Derek Hwang FCF
First Commonwealth Financial CFO Disposes of 2,072 Shares, Raising $37,006
FCF

James R. Reske, Executive Vice President and Chief Financial Officer of First Commonwealth Financial Corp (FCF), sold 2,072 shares of the bank's common stock on April 6, 2026, under a trading plan adopted in March 2025. The transactions generated $37,006 in proceeds at prices between $17.81 and $17.905. Reske continues to own 83,420 shares outright and holds service-based restricted stock units convertible on a 1-for-1 basis after three-year vesting.

Key Points

  • FCF CFO James R. Reske sold 2,072 shares on April 6, 2026, generating $37,006 in proceeds at prices between $17.81 and $17.905.
  • After the sales, Reske directly owns 83,420 shares and holds service-based RSUs totaling 22,150 units that vest on a 3-year schedule.
  • First Commonwealth Financial reported Q4 2025 EPS of $0.43 and revenue of $137.9 million, both above expectations; the company has a market cap of $1.85 billion and a P/E of 12.39.

Overview

James R. Reske, who serves as Executive Vice President and Chief Financial Officer at First Commonwealth Financial Corp (NYSE:FCF), executed a series of stock sales on April 6, 2026, according to a recent SEC Form 4 filing. The total number of shares sold was 2,072, for aggregate proceeds of $37,006. The transactions were carried out under a pre-existing trading plan that was adopted on March 20, 2025.


Details of the disposition

The sales consisted of multiple lots transacted at slightly different per-share prices, within a narrow band between $17.81 and $17.905. The breakdown of the individual lots reported in the Form 4 is as follows:

  • 99 shares at $17.81
  • 205 shares at $17.815
  • 100 shares at $17.825
  • 3 shares at $17.845
  • 600 shares at $17.85
  • 200 shares at $17.865
  • 200 shares at $17.87
  • 77 shares at $17.88
  • 60 shares at $17.885
  • 210 shares at $17.89
  • 180 shares at $17.895
  • 48 shares at $17.90
  • 90 shares at $17.905

The reported sales produced $37,006 in proceeds. At the time of reporting, the company’s common shares were trading at $18.13, a price level that represents a 33% increase over the past 12 months.


Post-transaction holdings and equity incentives

Following the April 6 transactions, Reske is listed as the direct owner of 83,420 shares of First Commonwealth Financial. In addition to those shares, the Form 4 discloses service-based restricted stock units (RSUs) that are convertible into common stock on a one-for-one basis after a three-year vesting period. The RSU awards reported include:

  • 8,000 shares awarded in 2024
  • 7,300 shares awarded in 2025 (bringing the running total to 15,300)
  • 6,850 shares awarded in 2026 (bringing the total to 22,150)

These derivative securities remain subject to vesting schedules and are recorded separately from Reske’s direct stock ownership.


Regulatory filing and authorization

The Form 4 documenting the sales was signed on behalf of James R. Reske by Matthew C. Tomb, who executed the filing under a Power of Attorney. The trade executions were made pursuant to the trading plan adopted on March 20, 2025, as disclosed in the filing.


Company financial snapshot

First Commonwealth Financial has a market capitalization of $1.85 billion and trades at a price-to-earnings ratio of 12.39. The company has a documented record of dividend continuity extending 40 consecutive years, with a current dividend yield reported at 2.98%. Investors can consult the company’s Pro Research Report, which is noted as part of a larger library of research reports available to subscribers.


Recent operating results

In related corporate disclosures, First Commonwealth Financial reported fourth-quarter 2025 results that exceeded analysts’ expectations. The company posted earnings per share of $0.43, marginally above the $0.42 estimate. Revenue for the quarter came in at $137.9 million versus consensus expectations of $135.63 million. Management provided optimistic guidance for 2026. The company has not announced any mergers or acquisitions and there were no analyst upgrades or downgrades reported in the immediate aftermath of the earnings release. No other material company developments have been disclosed.


What this filing shows

The Form 4 offers a precise record of an executive sale executed under an established plan, the executive’s retained direct holdings, and the presence of service-based equity incentives subject to future vesting. The filing also identifies the authorized signer and confirms the March 20, 2025 trading plan as the framework for these transactions.

All elements in this report are drawn from the company’s SEC disclosure and the company’s reported quarterly results as described above.

Risks

  • Reske’s RSUs are subject to a 3-year vesting schedule - these derivative awards may not convert to shares until the vesting conditions are satisfied, which affects future insider ownership levels - impacts equity investors and corporate governance.
  • The insider sale occurred at modest per-share price variation within the trading plan; future sales under the plan could change available float and influence short-term liquidity - impacts market traders and regional banking investors.
  • Company guidance for 2026 is described as optimistic, but no subsequent analyst upgrades or downgrades were recorded; absent analyst action, market reassessment could be delayed - impacts investor sentiment in the banking sector.

More from Insider Trading

Vir Biotechnology CEO Executes $664K Sale Under 10b5-1 Plan; Company Raises $172.5M in Offering Apr 7, 2026 United Therapeutics CFO Disposes $5.58M in Stock, Exercises Options for 10,000 Shares Apr 7, 2026 Alnylam CHRO Sells $1.27 Million in Stock; Keeps 9,443 Shares Apr 7, 2026 Oscar Health CEO Executes Large Share Transactions as Stock Climbs 11% Apr 7, 2026 AH Realty Trust Director Increases Stake with $5,747 in Purchases Apr 7, 2026